Get started
Author

Nicola Stefano Fracchiolla

Observed names: N S Fracchiolla, N. Fracchiolla, N. S. Fracchiolla, N.S. Fracchiolla, Nicola Fracchiolla, Nicola S Fracchiolla, Nicola S. Fracchiolla
ORCID: 0000-0002-5356-8690
Observed ORCID: 0000-0002-5356-8690
OpenAlex ID: A5107971635
Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study
2020 · Francesco Passamonti, Chiara Cattaneo, et al. · The Lancet Haematology · 545
PDF
COVID‐19 elicits an impaired antibody response against SARS‐CoV‐2 in patients with haematological malignancies
2021 · Francesco Passamonti, Alessandra Romano, et al. · British Journal of Haematology · 62
PDF
A prognostic model for patients with lymphoma and COVID-19: a multicentre cohort study
2021 · Carlo Visco, Luigi Marcheselli, et al. · Blood Advances · 55
PDF
Updated risk-oriented strategy for acute lymphoblastic leukemia in adult patients 18–65 years: NILG ALL 10/07
2020 · Renato Bassan, Chiara Pavoni, et al. · Blood Cancer Journal · 45
PDF
Dasatinib-Blinatumomab Combination for the Front-Line Treatment of Adult Ph+ ALL Patients. Updated Results of the Gimema LAL2116 D-Alba Trial
2019 · Sabina Chiaretti, Renato Bassan, et al. · Blood · 37
Efficacy and Toxicity of Frontline Ponatinib Plus Blinatumomab for Adult Ph+ ALL Patients of All Ages. Intermediate Analysis of the Gimema ALL2820
2024 · Sabina Chiaretti, Matteo Leoncin, et al. · Blood · 33
Clinical significance of occult central nervous system disease in adult acute lymphoblastic leukemia. A multicenter report from the Campus ALL Network
2019 · Maria Ilaria Del Principe, Elisa Buzzatti, et al. · Haematologica · 32
PDF
P353: Forty Months Update of the Gimema Lal2116 (d-alba) Protocol and Ancillary Lal2217 Study for Newly Diagnosed Adult Ph+ All
2022 · S. Chiaretti, R. Bassan, et al. · HemaSphere · 28
Bcl-2 protein expression and p53 gene mutation in chronic lymphocytic leukemia: correlation with in vitro sensitivity to chlorambucil and purine analogs.
1997 · F Morabito, M Filangeri, et al. · PubMed · 28
Incidence, treatment and outcome of central nervous system relapse in adult acute lymphoblastic leukaemia patients treated front‐line with paediatric‐inspired regimens: A retrospective multicentre Campus ALL study
2022 · Michelina Dargenio, Massimiliano Bonifacio, et al. · British Journal of Haematology · 20
PDF
Age, successive waves, immunization, and mortality in elderly COVID-19 hematological patients: EPICOVIDEHA findings
2023 · Giuseppe Rossi, Jon Salmanton-García, et al. · International Journal of Infectious Diseases · 19
PDF
Clinical impact of ceftazidime/avibactam on the treatment of suspected or proven infections in a large cohort of patients with haematological malignancies: a multicentre observational real-world study
2024 · Mario Tumbarello, Gabriele Giuliano, et al. · Journal of Antimicrobial Chemotherapy · 17
Clinical, Morphological and Clonal Progression of VEXAS Syndrome in the Context of Myelodysplasia Treated with Azacytidine
2022 · Marco Manzoni, Alessandro Bosi, et al. · Clinical Hematology International · 17
PDF
Survival in multiple myeloma and SARS‐COV‐2 infection through the COVID‐19 pandemic: Results from the EPICOVIDEHA registry
2023 · Pellegrino Musto, Jon Salmanton‐García, et al. · Hematological Oncology · 16
PDF
First results of the Phase III GIMEMA ALL2820 trial comparing ponatinib plus blinatumomab to imatinib and chemotherapy for newly diagnosed adult ph+ acute lymphoblastic leukemia patients
2025 · Sabina Chiaretti, Mariangela Di Trani, et al. · Blood · 14
PDF
SARS‐CoV‐2 infection in patients with chronic lymphocytic leukemia: The Italian Hematology Alliance on COVID‐19 cohort
2022 · Michele Merli, Isacco Ferrarini, et al. · Hematological Oncology · 14
PDF
Possible association between reactive oxygen metabolites and karyotypic abnormalities in myelodysplastic syndromes.
2003 · Nicola S Fracchiolla, Fabrizia Bamonti Catena, et al. · PubMed · 10
Secondary infections worsen the outcome of COVID‐19 in patients with hematological malignancies: A report from the ITA‐HEMA‐COV
2022 · Patrizia Zappasodi, Chiara Cattaneo, et al. · Hematological Oncology · 9
PDF
Outcomes of allogeneic stem cell transplant in adult Philadelphia negative acute lymphoblastic leukemia patients treated with the pediatric-inspired GIMEMA 1913 protocol. A Campus ALL study
2025 · Gianluca Cavallaro, Davide Lazzarotto, et al. · Bone Marrow Transplantation · 8
PDF
Outcome of 421 adult patients with Philadelphia-negative acute lymphoblastic leukemia treated under an intensive program inspired by the GIMEMA LAL1913 clinical trial: a Campus ALL study
2024 · Davide Lazzarotto, Marco Cerrano, et al. · Haematologica · 8
PDF
Gilteritinib in FLT3‐mutated acute myeloid leukemia: A real‐world Italian experience
2025 · Roberto Cairoli, Lorenzo Del Castello, et al. · Cancer · 7
PDF
Distinct Metabolic Profile Associated with a Fatal Outcome in COVID-19 Patients during the Early Epidemic in Italy
2021 · Elisa Saccon, Alessandra Bandera, et al. · Microbiology Spectrum · 7
S1617 a Dasatinib‐blinatumomab Combination for the Front‐line Treatment of Adult Ph+ All Patients. Preliminary Results of the Gimema Lal2116 D‐alba Trial; on Behalf of Gimema Acute Leukemia Working Party
2019 · S. Chiaretti, R. Bassan, et al. · HemaSphere · 7
In BCR-ABL1 Positive B-Cell Acute Lymphoblastic Leukemia, Steroid Therapy Induces Hypofibrinogenemia
2022 · Elisa Buzzatti, Fabio Forghieri, et al. · Journal of Clinical Medicine · 5
PDF
Real World Incidence and Etiology of Infectious Complications in Adults With Ph‐Negative Acute Lymphoblastic Leukemia Treated With the Pediatric‐Inspired GIMEMA LAL1913 Program. A Campus All Study
2025 · Patrizia Zappasodi, Ludovica Calabretta, et al. · Hematological Oncology · 4
PDF
Works count: 66
Citation count: 1,079
H-index: 14
I10-index: 17
Year
Topic
Type